Michael E. Faerm
Director of Finance/CFO at VIRACTA THERAPEUTICS, INC.
Profile
Michael E.
Faerm is currently the Chief Financial & Accounting Officer at Viracta Therapeutics, Inc. He previously held positions as an Associate Director at Forest Laboratories, Inc. and Regeneron Pharmaceuticals, Inc. He also worked as an Analyst at Credit Suisse Securities (USA) LLC and Wells Fargo Securities LLC.
Additionally, he served as the Chief Business Officer & Senior Vice President at Innoviva, Inc. and as the Vice President at Merrill Lynch & Co., Inc. He has also held the role of Chief Financial Officer at Harpoon Therapeutics, Inc. and Artiva Biotherapeutics, Inc. Mr. Faerm obtained his undergraduate degree from The Trustees of Columbia University in The City of New York, his graduate degree from Stanford University, and his MBA from Harvard Business School.
Michael E. Faerm active positions
| Companies | Position | Start |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Director of Finance/CFO | 13/05/2024 |
Former positions of Michael E. Faerm
| Companies | Position | End |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2024 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/03/2023 |
| INNOVIVA, INC. | Corporate Officer/Principal | 07/02/2018 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/01/2006 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2004 |
Training of Michael E. Faerm
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Stanford University | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| HARPOON THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
| Merrill Lynch & Co., Inc. | Finance |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Wells Fargo Securities LLC
 Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Finance |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Michael E. Faerm